drugset / Trial / NCT02301091
Combine TACE and RFA Versus TACE Alone for HCC With PVTT
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether combined radiofrequency ablation and transcatheter chemoembolization (TACE) result in better survival outcomes than TACE alone in patients with HCC and portal vein tumor thrombus.
Timeline
- Start
- 2014-10
- Primary completion
- 2018-10
- Completion
- 2019-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Lobaplatin | Small molecule | — | Other |
| Background | Mitomycin C | Other / unclassified | — | Other |
| Background | Pirarubicin | Small molecule | — | Other |